Objective: To review the role of ursodeoxycholic acid (ursodiol) in treating parenteral
nutrition–associated cholestasis (PNAC). Data Sources: A MEDLINE (1950–May 2007) …

Sarcoidosis is a multisystem inflammatory disease, which is characterized by the
development of noncaseating granulomas amid healthy tissue. While most commonly …

Background The prevention and treatment of liver disease associated with cystic fibrosis
remain a significant unresolved problem. Aim To assess the long‐term effects of continuous …

Parenteral nutrition is a life-saving therapy in patients with intestinal failure. One of the major
causes of morbidity and mortality in patients receiving long-term total parenteral nutrition …

Chronic liver diseases that inevitably lead to hepatic fibrosis, cirrhosis and/or hepatocellular
carcinoma have become a major cause of illness and death worldwide. Among them …

IFALD is a common and potentially life‐threatening condition for patients with SBS requiring
long‐term PN. There exists the potential for decreasing its incidence by optimizing the …

We report three Japanese patients with psoriasis vulgaris associated with nonalcoholic fatty
liver disease in which the skin lesions dramatically resolved after treatment of the fatty liver …

The COVID-19 pandemic has resulted in significant worldwide morbidity and mortality. In
this review, we examine the intricate relationships between COVID-19 and liver diseases …

Introduction: Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming one of most
common liver diseases in industrialized countries owing to the increasing prevalence of …

Fatigue is an important symptom and a quality of life determinant in patients with cholestatic
liver disease. The pathogenesis of fatigue is obscure, although alterations in central …